Zynerba Pharmaceuticals, Inc. (ZYNE) Reaches $10.51 After 6.00% Up Move; Ellington Management Group Increased Mgic Invt Wis (MTG) Holding

May 31, 2018 - By Vivian Park

MGIC Investment Corporation (NYSE:MTG) Logo

Ellington Management Group Llc increased Mgic Invt Corp Wis (MTG) stake by 60.38% reported in 2018Q1 SEC filing. Ellington Management Group Llc acquired 25,600 shares as Mgic Invt Corp Wis (MTG)’s stock declined 26.95%. The Ellington Management Group Llc holds 68,000 shares with $884,000 value, up from 42,400 last quarter. Mgic Invt Corp Wis now has $3.90 billion valuation. The stock decreased 0.76% or $0.08 during the last trading session, reaching $10.49. About 1.62M shares traded. MGIC Investment Corporation (NYSE:MTG) has declined 2.69% since May 31, 2017 and is downtrending. It has underperformed by 15.26% the S&P500.

The stock of Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) is a huge mover today! The stock increased 3.14% or $0.32 during the last trading session, reaching $10.51. About 89,146 shares traded. Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) has declined 46.38% since May 31, 2017 and is downtrending. It has underperformed by 58.95% the S&P500.The move comes after 5 months positive chart setup for the $142.53M company. It was reported on May, 31 by Barchart.com. We have $11.14 PT which if reached, will make NASDAQ:ZYNE worth $8.55 million more.

Investors sentiment decreased to 0.88 in 2018 Q1. Its down 0.44, from 1.32 in 2017Q4. It dropped, as 38 investors sold MTG shares while 100 reduced holdings. 35 funds opened positions while 87 raised stakes. 331.27 million shares or 1.30% less from 335.64 million shares in 2017Q4 were reported. Victory Capital Mngmt Inc reported 0.13% in MGIC Investment Corporation (NYSE:MTG). Japan-based Legg Mason Asset Mngmt (Japan) Ltd has invested 0.83% in MGIC Investment Corporation (NYSE:MTG). Prudential Public Ltd Com has invested 0% of its portfolio in MGIC Investment Corporation (NYSE:MTG). Morgan Stanley stated it has 1.59M shares. Dupont Management Corp has invested 0.1% in MGIC Investment Corporation (NYSE:MTG). Group One Trading LP has 0.02% invested in MGIC Investment Corporation (NYSE:MTG) for 142,206 shares. Gsa Llp owns 0.05% invested in MGIC Investment Corporation (NYSE:MTG) for 65,729 shares. Sterling Management owns 171,318 shares. Glenmede Tru Na holds 34,092 shares. Teachers Retirement Systems Of The State Of Kentucky invested in 119,501 shares or 0.02% of the stock. Moreover, Advsr Cap Mngmt Ltd Company has 0.25% invested in MGIC Investment Corporation (NYSE:MTG) for 258,913 shares. Anchor Ltd Com, a Massachusetts-based fund reported 33,232 shares. Silvercrest Asset Group Inc Ltd holds 0.01% in MGIC Investment Corporation (NYSE:MTG) or 74,500 shares. Putnam Invests Limited Liability Com invested 0% in MGIC Investment Corporation (NYSE:MTG). Royal Commercial Bank Of Canada reported 38,566 shares stake.

Among 14 analysts covering MGIC Investment Corp. (NYSE:MTG), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. MGIC Investment Corp. had 54 analyst reports since August 12, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, October 17 by Bank of America. The firm earned “Buy” rating on Thursday, April 13 by Compass Point. FBR Capital maintained the stock with “Mkt Perform” rating in Friday, October 16 report. Deutsche Bank maintained the stock with “Buy” rating in Friday, July 21 report. Keefe Bruyette & Woods maintained MGIC Investment Corporation (NYSE:MTG) on Tuesday, April 10 with “Buy” rating. On Wednesday, August 30 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. The stock of MGIC Investment Corporation (NYSE:MTG) earned “Buy” rating by FBR Capital on Thursday, January 18. On Tuesday, July 18 the stock rating was maintained by BTIG Research with “Buy”. RBC Capital Markets maintained MGIC Investment Corporation (NYSE:MTG) on Thursday, January 18 with “Buy” rating. The firm has “Neutral” rating given on Tuesday, May 10 by Compass Point.

Ellington Management Group Llc decreased Visa Inc (NYSE:V) stake by 10,600 shares to 5,100 valued at $610,000 in 2018Q1. It also reduced Petroleo Brasileiro Sa Petro stake by 47,959 shares and now owns 55,300 shares. Garmin Ltd (NASDAQ:GRMN) was reduced too.

Zynerba Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company has market cap of $142.53 million. The Company’s product candidates include ZYN002, which is in Phase II clinical trial for adult patients with refractory epileptic focal seizures and osteoarthritis, as well as pediatric patients with fragile X syndrome; and ZYN001 that is in preclinical stage for the treatment of fibromyalgia and peripheral neuropathic pain. It currently has negative earnings. The firm was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014.

More important recent Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) news were published by: Seekingalpha.com which released: “Zynerba: Transdermal Cannabinoids Have Significant Potential” on May 15, 2018, also Prnewswire.com published article titled: “Medical Cannabis Market Projects Growth Across North America”, Nasdaq.com published: “Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights” on May 08, 2018. More interesting news about Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) was released by: Prnewswire.com and their article: “The Tech Revolutionizing the Billion Dollar Marijuana Business” with publication date: May 29, 2018.

Analysts await Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) to report earnings on August, 7. They expect $-0.68 earnings per share, down 6.25% or $0.04 from last year’s $-0.64 per share. After $-0.91 actual earnings per share reported by Zynerba Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -25.27% EPS growth.

MGIC Investment Corporation (NYSE:MTG) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: